GANGLIONIC TRANSMISSION IS A PREREQUISITE FOR THE ADRENALINE-RELEASING AND HYPERGLYCEMIC EFFECTS OF 8-OH-DPAT

被引:49
作者
CHAOULOFF, F
LAUDE, D
BAUDRIE, V
机构
[1] Laboratoire de Pharmacologie, Groupe de Neuropharmacologie, CNRS
关键词
5-HT[!sub]1A[!/sub] receptors; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); Adrenaline; Corticosterone; Ganglionic blockade; Glycemia; Hexamethonium;
D O I
10.1016/0014-2999(90)90205-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study concerned the influence of ganglionic nicotinic blockade (by hexamethonium, 5 mg/kg and 10 mg/kg) of the 8-OH-DPAT-induced elevations in plasma adrenaline, corticosterone and glucose levels in conscious rats. Prior treatment with hexamethonium dose dependently decreased the basal glucose levels and increased the basal corticosterone levels but did not significantly affect the basal adrenaline levels. Hexamethonium decreased in a dose-dependent manner the elevations in plasma adrenaline, corticosterone and glucose levels that were elicited by the 5-HT1A receptor agonist, 8-OH-DPAT (0.25 mg/kg). These results indicate that acetylcholine release is a prerequisite for both the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT. The data also point to the possibility that adrenaline release participates in the elevation in plasma corticosterone levels that is elicited by 5-HT1A receptor activation. © 1990.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 20 条
[1]  
ANTON AH, 1962, J PHARMACOL EXP THER, V138, P360
[2]   MARKED INCREASES IN PLASMA-CATECHOLAMINE CONCENTRATIONS PRECEDE HYPOTENSION AND BRADYCARDIA CAUSED BY 8-HYDROXY-2-(DI-N-PROPYLAMINO) TETRALIN (8-OH-DPAT) IN CONSCIOUS RATS [J].
BAGDY, G ;
SZEMEREDI, K ;
MURPHY, DL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (04) :270-272
[3]   SEROTONIN AGONISTS CAUSE PARALLEL ACTIVATION OF THE SYMPATHOADRENOMEDULLARY SYSTEM AND THE HYPOTHALAMO-PITUITARY-ADRENOCORTICAL AXIS IN CONSCIOUS RATS [J].
BAGDY, G ;
CALOGERO, AE ;
MURPHY, DL ;
SZEMEREDI, K .
ENDOCRINOLOGY, 1989, 125 (05) :2664-2669
[4]  
BOUHELAL R, 1990, BRIT J PHARMACOL, V99, pP38
[5]   PENTOBARBITAL-ANESTHESIA PREVENTS THE ADRENALINE-RELEASING EFFECT OF THE 5-HT1A RECEPTOR AGONIST, 8-HYDROXY-2-(DI-N-PROPYLAMINO) TETRALIN [J].
CHAOULOFF, F ;
BAUDRIE, V ;
LAUDE, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 180 (01) :175-178
[6]  
CHAOULOFF F, 1987, J PHARMACOL EXP THER, V243, P1159
[7]   EVIDENCE THAT THE 5-HT1A RECEPTOR AGONISTS BUSPIRONE AND IPSAPIRONE ACTIVATE ADRENALINE RELEASE IN THE CONSCIOUS RAT [J].
CHAOULOFF, F ;
BAUDRIE, V ;
LAUDE, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 177 (1-2) :107-110
[8]  
CHAOULOFF F, 1990, N-S ARCH PHARMACOL, V341, P381
[9]  
CHAOULOFF F, 1990, BRIT J PHARMACOL, V99, pP39
[10]  
FOZARD J R, 1985, British Journal of Pharmacology, V86, p601P